Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2020-10-16
Buyer: Sykehusinnkjøp HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 9800000 NOK
Award criteria: Lowest price

Technical requirements: Additional contracts with Boehringer Ingelheim after the tender competition LIS 2001c special pharmaceutical preparations B01AD11 Metalyse.
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender contest for special pharmaceutical preparations ('LIS 2001c Parentale special pharmaceutical preparations’). The competition included the active ingredients that were in accordance with the tender documentation, annex 3 — the Active Ingredients List.
After the award of contracts, a new requirement has arisen for the award of contracts for the delivery of Metalyse (ATC code B01AD11) due to the current agreement expires 31 January 2021, one year before the other agreements in LIS 2001c and there were no other suppliers of the active ingredients in the call for tenders regarding contract LIS 2001c.
Due to this, LIS intends to enter into contracts between the regional health trusts (the Contracting Authorities) and Boehringer Ingelheim (the Supplier) as an additional contract to LIS 2001c. I.e. the scope and length of the contract shall be in accordance with the terms in the mentioned call for tenders (including access to extensions and conclusion of contract), without a new call for tenders being published for this ingredient. The health companies that are under the regional health trusts have an option to enter into the contracts.
LIS has examined the market situation and is of the opinion that it is not possible to have a new competition, or that another supplier than Boehringer Ingelheim can deliver the product in this contract period. In addition, the situation that has occurred is not the contracting authority's fault, nor something that the contracting authority could foresee. LIS therefore believes that there are grounds to make the procurement without a competition. See the public procurement regulations, § 21-5, cf. § 21-2, cf. § 13-4 no. 2 and letter a, also cf. § 13-3 letter e.
LIS requests that those who have objections to this submit feedback before the waiting period expires on 19.10.2020. If no objections are received, a contract will be signed after the waiting period has expired.
LIS has examined the market situation and is of the opinion that it is not possible to have a new competition, or that another supplier than Boehringer Ingelheim can deliver the product in this contract period. In addition, the situation that has occurred is not the contracting authority´s fault, nor something that the contracting authority could foresee. LIS therefore believes that there are grounds to make the procurement without a competition. See the public procurement regulations, § 21-5, cf. § 21-2, cf. § 13-4 no. 2 and letter a, also cf. § 13-3 letter e.
LIS requests that those who have objections to this submit feedback before the waiting period expires on 7 December 2018. If no objections are received, a contract will be signed after the waiting period has expired.


Winner: Boehringer Ingelheim Norway KS
Award value: 9800000